GGrantIndex
← Leaderboards

Sarah J Parker

Cedars-Sinai Medical Center

$4,415,288
Attributed
$4,415,288
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $835K · FY201625
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,415,288 · 4

By mechanism

R01$3,340,000 · 2
R00$733,304 · 1
K99$341,984 · 1

Top collaborators

No co-investigators on record.

Most similar at Cedars-Sinai Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Prevent

Research focus

PreventCell TypePathway InteractionsTherapeutic TargetInsightBiologyMediatingMouse ModelSignal TransductionGenesIn VitroIn VivoFunctional DisorderBiologicalAngiotensin IiFbn1AneurysmIn Vitro ModelLinkDesignAffectDissectionBlood VesselsAortic Aneurysm

Grant awards (13)

Asporin, an extracellular protein, regulates cardiac remodeling$417,500
R01 · FY2025 · HL · contact PI
Mechanisms of sex-biased risk and resiliency in aneurysm and dissection$417,500
R01 · FY2025 · HL · contact PI
Mechanisms of sex-biased risk and resiliency in aneurysm and dissection$417,500
R01 · FY2024 · HL · contact PI
Asporin, an extracellular protein, regulates cardiac remodeling$417,500
R01 · FY2024 · HL · contact PI
Mechanisms of sex-biased risk and resiliency in aneurysm and dissection$417,500
R01 · FY2023 · HL · contact PI
Asporin, an extracellular protein, regulates cardiac remodeling$417,500
R01 · FY2023 · HL · contact PI
Mechanisms of sex-biased risk and resiliency in aneurysm and dissection$417,500
R01 · FY2022 · HL · contact PI
Asporin, an extracellular protein, regulates cardiac remodeling$417,500
R01 · FY2022 · HL · contact PI
Mapping the Angiotensin II-TGFB-Integrin Signaling Triad to reveal Therapeutic Targets in Aortic Aneurysm$244,356
R00 · FY2020 · HL · contact PI
Mapping the Angiotensin II-TGFB-Integrin Signaling Triad to reveal Therapeutic Targets in Aortic Aneurysm$244,356
R00 · FY2019 · HL · contact PI
Mapping the Angiotensin II-TGFB-Integrin Signaling Triad to reveal Therapeutic Targets in Aortic Aneurysm$244,592
R00 · FY2018 · HL · contact PI
Mapping the Angiotensin II-TGFB-Integrin signaling triad to reveal therapeutic targets in aortic aneurysm$170,992
K99 · FY2017 · HL · contact PI
Mapping the Angiotensin II-TGFB-Integrin signaling triad to reveal therapeutic targets in aortic aneurysm$170,992
K99 · FY2016 · HL · contact PI